CD40LG and lymphoma: As for the evaluation of CSR in vitro, murine CH12F3-2A lymphoma cells [22] and primary splenic B cells have been proven to proceed with consistent switching in vitro, which could change IgM to other immunoglobulins in response to a variety of stimulations, such as CD40L, IL-4, TGF-β, and LPS.